BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 20814119)

  • 1. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
    Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of different doses and types of intravenous iron on oxidative stress and inflammation in hemodialysis patients.
    Kumbasar A; Gursu M; Kaya C; Ozturk S; Ergen A; Kemik A; Aydin Z; Uzun S; Karadag S; Kazancioglu R
    J Nephrol; 2012; 25(5):825-32. PubMed ID: 22307439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
    Saglam F; Cavdar C; Uysal S; Cavdar Z; Camsari T
    Ren Fail; 2007; 29(7):849-54. PubMed ID: 17994454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and subacute effects of EV iron sucrose on endothelial functions in hemodialysis patients.
    Ozkurt S; Ozenc F; Degirmenci NA; Temiz G; Musmul A; Sahin G; Yalcin AU
    Ren Fail; 2012; 34(1):1-6. PubMed ID: 22017464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of N-acetylcysteine on aluminum phosphide-induced oxidative stress in acute human poisoning.
    Tehrani H; Halvaie Z; Shadnia S; Soltaninejad K; Abdollahi M
    Clin Toxicol (Phila); 2013 Jan; 51(1):23-8. PubMed ID: 23148565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
    Tam LS; Li EK; Leung VY; Griffith JF; Benzie IF; Lim PL; Whitney B; Lee VW; Lee KK; Thomas GN; Tomlinson B
    J Rheumatol; 2005 Feb; 32(2):275-82. PubMed ID: 15693087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
    Jenq CC; Tian YC; Wu HH; Hsu PY; Huang JY; Chen YC; Fang JT; Yang CW
    Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
    Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
    Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Prabhu A; Sujatha DI; Kanagarajan N; Vijayalakshmi MA; Ninan B
    Ann Vasc Surg; 2009; 23(5):645-51. PubMed ID: 19467834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?
    Koechlin C; Couillard A; Simar D; Cristol JP; Bellet H; Hayot M; Prefaut C
    Am J Respir Crit Care Med; 2004 May; 169(9):1022-7. PubMed ID: 15001462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
    Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
    Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.
    Wikström B; Bhandari S; Barany P; Kalra PA; Ladefoged S; Wilske J; Thomsen LL
    J Nephrol; 2011; 24(5):589-96. PubMed ID: 21240875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
    Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C
    Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis.
    Garcia-Fernandez N; Echeverria A; Sanchez-Ibarrola A; Páramo JA; Coma-Canella I
    Nephrology (Carlton); 2010 Mar; 15(2):178-83. PubMed ID: 20470276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of preconditioning and N-acetylcysteine on oxidative stress resulting from tourniquet-induced ischemia-reperfusion in arthroscopic knee surgery.
    Koca K; Yurttas Y; Cayci T; Bilgic S; Kaldirim U; Durusu M; Cekli Y; Ozkan H; Hanci V; Purtuloglu T; Akgul EO; Oguz E; Yildiz C; Basbozkurt M
    J Trauma; 2011 Mar; 70(3):717-23. PubMed ID: 21610364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
    Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.